advisorsecurities master

ZYMEZymeworks Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
24226
Ticker
ZYME
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2017-04-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ZYME

Detail

Enriched 2026-08-14 20:47

Market cap
$1,769,013,878.13
Shares outstanding (class)
70,959,241
Shares outstanding (weighted)
70,959,241
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
264
Location
MIDDLETOWN, DE
Description

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data